التفاصيل البيبلوغرافية
| العنوان: |
Efficacy for Reduction of HbA1c and Body Weight by Oral Semaglutide (Rybelsus) |
| المؤلفون: |
Ogawa, H, Bando, Hiroshi, Abe, T, Nagahiro, Shinji, Nakanishi, M, Watanabe, O |
| بيانات النشر: |
SunText Reviews |
| سنة النشر: |
2024 |
| المجموعة: |
Tokushima University Institutional Repository / 徳島大学機関リポジトリ |
| مصطلحات موضوعية: |
Oral semaglutide (Rybelsus), Type 2 diabetes (T2D), Gastro Esophageal Reflux Disease (GERD), Gastrointestinal adverse effects (GIAEs), Sodium N-[8-(2-hydroxybenzoyl) amino] caprylate (SNAC) |
| الوصف: |
Background: Oral semaglutide (Rybelsus) has been recently in focus for type 2 diabetes (T2D). Case presentation: Case is 61-year-old female with T2D, obesity, fatty liver and Gastro Esophageal Reflux Disease (GERD). Her HbA1c was 13.2% in Dec 2021, and she started to have metformin, empagliflozin and Rybelsus from 3mg to 7mg/day. General situation was improved as -4.2% of HbA1c and -8kg in weight for 4 months. Discussion and Conclusion: This case has GERD, and then the doses of Rybelsus kept 7mg/day. She did not feel any gastrointestinal adverse effects (GIAEs). This impressive case will become reference for diabetic practice. |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| تدمد: |
27664813 |
| العلاقة: |
http://repo.lib.tokushima-u.ac.jp/files/public/11/119038/20240221175546882435/srmcr_3_3_162.pdfTest; http://repo.lib.tokushima-u.ac.jp/119038Test |
| الإتاحة: |
http://repo.lib.tokushima-u.ac.jp/119038Test |
| حقوق: |
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0Test/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| رقم الانضمام: |
edsbas.4A88543C |
| قاعدة البيانات: |
BASE |
